After almost two years of extensive review and deliberation, the Chinese legislature finally passed the new Drug Administration Law ("DAL") on August 26, 2019, which will go into effect on December 1, 2019.

The China Food and Drug Administration (CFDA) published its proposed amendment of the Drug Administration Law (DAL) and the Drug Registration Rules (DRR) for public comments. This Alert summarizes the key changes.

On May 19, 2017, China's State Council promulgated the amendments to the 2014 Regulation on the Supervision and Administration of Medical Devices ("the Amendments"), which became effective immediately.